Manulife (Manufacturers Life Insurance)’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $564K | Buy |
10,166
+4,484
| +79% | +$241K | ﹤0.01% | 2104 |
|
|
2025
Q4 | $275K | Sell |
5,682
-1,037
| -15% | -$40.4K | ﹤0.01% | 2393 |
|
|
2025
Q3 | $206K | Buy |
+6,719
| New | +$154K | ﹤0.01% | 2566 |
|
|
2025
Q2 | – | Sell |
-36,596
| Closed | -$680K | – | 2908 |
|
|
2025
Q1 | $680K | Buy |
36,596
+144
| +0.4% | +$2.4K | ﹤0.01% | 1988 |
|
|
2024
Q4 | $483K | Sell |
36,452
-5,594
| -13% | -$136K | ﹤0.01% | 2261 |
|
|
2024
Q3 | $1.41M | Buy |
42,046
+16,734
| +66% | +$572K | ﹤0.01% | 1732 |
|
|
2024
Q2 | $634K | Buy |
25,312
+8,418
| +50% | +$196K | ﹤0.01% | 2098 |
|
|
2024
Q1 | $380K | Sell |
16,894
-10,339
| -38% | -$245K | ﹤0.01% | 2304 |
|
|
2023
Q4 | $583K | Buy |
27,233
+8,739
| +47% | +$151K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $332K | Buy |
+18,494
| New | +$353K | ﹤0.01% | 2320 |
|
|
2023
Q1 | – | Sell |
-8,085
| Closed | -$251K | – | 2932 |
|
|
2022
Q4 | $251K | Sell |
8,085
-195
| -2% | -$5.51K | ﹤0.01% | 2416 |
|
|
2022
Q3 | $211K | Buy |
+8,280
| New | +$194K | ﹤0.01% | 2558 |
|
|
2022
Q2 | – | Sell |
-8,310
| Closed | -$206K | – | 3007 |
|
|
2022
Q1 | $206K | Sell |
8,310
-1,950
| -19% | -$59K | ﹤0.01% | 2758 |
|
|
2021
Q4 | $357 | Sell |
10,260
-410
| -4% | -$13K | ﹤0.01% | 2487 |
|
|
2021
Q3 | $289K | Sell |
10,670
-1,022
| -9% | -$25.9K | ﹤0.01% | 2698 |
|
|
2021
Q2 | $303K | Sell |
11,692
-1,032
| -8% | -$24.7K | ﹤0.01% | 2802 |
|
|
2021
Q1 | $274K | Sell |
12,724
-703
| -5% | -$17.7K | ﹤0.01% | 2671 |
|
|
2020
Q4 | $289K | Buy |
13,427
+159
| +1% | +$3.86K | ﹤0.01% | 2538 |
|
|
2020
Q3 | $196K | Hold |
13,268
| – | – | ﹤0.01% | 2575 |
|
|
2020
Q2 | $301K | Sell |
13,268
-2,887
| -18% | -$52.8K | ﹤0.01% | 2254 |
|
|
2020
Q1 | $228K | Buy |
16,155
+1,158
| +8% | +$17.6K | ﹤0.01% | 2243 |
|
|
2019
Q4 | $244K | Sell |
14,997
-468
| -3% | -$11.1K | ﹤0.01% | 2459 |
|
|
2019
Q3 | $545K | Buy |
15,465
+131
| +0.9% | +$6.23K | ﹤0.01% | 1966 |
|
|
2019
Q2 | $865K | Buy |
15,334
+1,427
| +10% | +$103K | ﹤0.01% | 1720 |
|
|
2019
Q1 | $1.02M | Buy |
13,907
+1,532
| +12% | +$106K | ﹤0.01% | 1683 |
|
|
2018
Q4 | $789K | Sell |
12,375
-55
| -0.4% | -$4.09K | ﹤0.01% | 1698 |
|
|
2018
Q3 | $1.24M | Sell |
12,430
-1,442
| -10% | -$120K | ﹤0.01% | 1672 |
|
|
2018
Q2 | $986K | Buy |
13,872
+550
| +4% | +$46.1K | ﹤0.01% | 1898 |
|
|
2018
Q1 | $1.39M | Sell |
13,322
-433
| -3% | -$48.8K | ﹤0.01% | 1657 |
|
|
2017
Q4 | $1.39M | Buy |
13,755
+4,034
| +41% | +$297K | ﹤0.01% | 1661 |
|
|
2017
Q3 | $339K | Buy |
9,721
+9,648
| +13,216% | +$260K | ﹤0.01% | 2549 |
|
|
2017
Q2 | $2K | Buy |
+73
| New | +$1.83K | ﹤0.01% | 4100 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
